Pharma Giant Signs Deal to Manufacture Drugs in Orbit, Marking First Commercial Space Manufacturing Pact

By

A startup aiming to produce pharmaceuticals in outer space has secured its first major commercial partner, signaling a milestone for orbital manufacturing. Varda Space Industries announced it has signed United Therapeutics to launch drugs into microgravity to form novel crystal structures.

The agreement represents what Varda calls 'the first commercial path to products made in space,' according to Michael Reilly, the company's chief strategy officer. United Therapeutics CEO Martine Rothblatt, a satellite veteran, said orbital conditions could yield 'even more amazing' versions of existing medicines.

Background

Previously, small-scale experiments on the International Space Station tested how weightlessness affects chemical mixtures—water becomes a wobbly sphere when gravity is absent. Now, Varda plans to send United Therapeutics' drugs into orbit so they can crystallize under microgravity, potentially creating atomic arrangements impossible on Earth.

Varda, based in El Segundo, California, was founded in 2021 by Delian Asparouhov and former SpaceX engineer Will Bruey. The company bets that falling launch costs and frequent rocket flights will make it profitable to ship raw materials into space, process them, and return the finished products to Earth.

What This Means

Pharmaceutical companies often reformulate blockbuster drugs to extend patent protection—switching from pills to inhalers, for example. United Therapeutics has used this strategy for lung disease drugs. Now Varda positions itself as a reformulation partner using orbital facilities instead of terrestrial technologies like nebulizers or nanoparticles.

If successful, this partnership could open a new frontier for drug development. The hope is that microgravity crystals exhibit superior stability or other valuable properties, yielding 'improved versions' that keep imitators at bay. However, the concept remains unproven at commercial scale.

This is a breaking news story. Updates will follow as more details emerge.

Related Articles

• Shocking Find: Fat Cell Protein HSL Has Secret Role That Reverses Obesity Assumptions
• AI Agents and Enterprise IAM: A Trust Gap That Must Be Resolved
• The Virtue of Laziness in an AI-Driven World: Reflections from the Pragmatic Summit
• Reclaiming the American Dream: Urgent Steps to Preserve Opportunity for All
• Transform Your Meal Prep: How to Import Recipes from YouTube and TikTok into Mealie for Healthy Eating
• Declarative Node Readiness Gates: A New Approach to Kubernetes Scheduling
• How to Track Antibiotic Resistance in Soil Amidst Climate Change: A Step-by-Step Guide Based on an 11-Year Study
• Revolutionary DNA Therapy Slashes 'Bad' Cholesterol by Half, Bypassing Statins